{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:15Z","timestamp":1790283315351,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108756","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:39:36Z","timestamp":1777617576000},"page":"108756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adjuvant multisite bacteriophage cocktail administration as salvage treatment in a patient with a multidrug-resistant Pseudomonas aeruginosa frontal relapsing complex osteitis"],"prefix":"10.1016","volume":"169","author":[{"given":"Aurore","family":"Denis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Jegoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Menez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Briot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gomes Von Borowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Fevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Le Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Revest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-7305","authenticated-orcid":false,"given":"David","family":"Luque Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108756_bib0001","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00579-25","article-title":"Complementary killing activities of pbunavirus LS1 and bruynoghevirus LUZ24 phages on planktonic and sessile Pseudomonas aeruginosa PAO1 derivatives","volume":"69","author":"Billaud","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108756_bib0002","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","article-title":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","volume":"13","author":"Ferry","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108756_bib0003","first-page":"49","article-title":"Phage therapy in bone and joint infection: history, scientific basis, feasibility and perspectives in France","volume":"24","author":"Ferry","year":"2020","journal-title":"Virologie (Montrouge)"},{"key":"10.1016\/j.ijid.2026.108756_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107372","article-title":"Access to phage therapy at Hospices Civils de Lyon in 2022: implementation of the PHAGEinLYON Clinic programme","volume":"64","author":"Ferry","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2026.108756_bib0005","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/jac\/dky263","article-title":"Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages","volume":"73","author":"Ferry","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2026.108756_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/aem.02095-25","article-title":"Phage cocktails containing a dual-receptor phikzvirus suppress resistance evolution in Pseudomonas aeruginosa","volume":"92","author":"Fujiki","year":"2026","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijid.2026.108756_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.108756_bib0008","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/v15051210","article-title":"Successful bacteriophage-antibiotic combination therapy against multidrug-resistant Pseudomonas aeruginosa left ventricular assist device driveline infection","volume":"15","author":"Racenis","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2026.108756_bib0009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/v15030602","article-title":"Administration of bacteriophages via nebulization during mechanical ventilation: in vitro study and lung deposition in macaques","volume":"15","author":"Le Guellec","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2026.108756_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijid.2026.108756_bib0011","article-title":"The synergistic effect between phages and ceftolozane\/tazobactam in Pseudomonas aeruginosa endotracheal tube biofilm","volume":"13","author":"Oliveira V de","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijid.2026.108756_bib0012","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage\u2013antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijid.2026.108756_bib0013","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/v17081080","article-title":"Biocontrol of phage resistance in Pseudomonas infections: insights into directed breaking of spontaneous evolutionary selection in phage therapy","volume":"17","author":"Fujiki","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2026.108756_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:40:29Z","timestamp":1781577629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":14,"alternative-id":["S1201971226003917"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108756","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant multisite bacteriophage cocktail administration as salvage treatment in a patient with a multidrug-resistant Pseudomonas aeruginosa frontal relapsing complex osteitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108756"}}